Esperion Therapeutics, Inc. (ESPR)
Pharmaceutical Preparations
Latest Price
$3.18
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
65.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 17.85M | $48.0M | 7.10% | +170.2K | 2026-03-31 |
| WASATCH ADVISORS LP | 15.77M | $43.0M | 6.27% | +6.32M | 2026-03-31 |
| Two Seas Capital LP | 11.39M | $31.0M | 4.53% | -507.7K | 2026-03-31 |
| ORBIMED ADVISORS LLC | 10.57M | $28.0M | 4.21% | +4.60M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.43M | $28.0M | 4.15% | -- | 2026-03-31 |
| MARSHALL WACE, LLP | 7.08M | $19.0M | 2.81% | +1.60M | 2026-03-31 |
| STATE STREET CORP | 7.06M | $19.0M | 2.81% | +1.13M | 2026-03-31 |
| D. E. Shaw & Co., Inc. | 6.54M | $17.0M | 2.60% | -362.7K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 5.96M | $16.0M | 2.37% | +218.1K | 2026-03-31 |
| AIGH Capital Management LLC | 4.40M | $12.0M | 1.75% | +400.0K | 2026-03-31 |